Clinical trial
Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer…
NCT00180869 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed
Key facts
| NCT number | NCT00180869 |
|---|---|
| Title | Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients |
| Official title | A Randomized Study of Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion During Surgery in Cancer Patients |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Surgery |
| Intervention type | Procedure |
| Interventions | transfusion of allogeneic red blood cell concentrate, transfusion of leuko-reduced red blood cell concentrate |
| Enrollment | 150 |
| Start date | Sep 1, 1997 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: